The Gleason Score is a grading system used to evaluate the prognosis of men with prostate cancer, based on the microscopic appearance of cancer cells in a biopsy. It helps in determining the aggressiveness of the cancer and guides treatment decisions by assigning a score from 6 to 10, with higher scores indicating more aggressive cancer.